Toggle navigation
Home
Search
Services
Blog
Contact
About
Cellular-Harvey-Ras Activation During Cisplatin-Initiate
Nelson, Mark A.
University of Arizona, Tucson, AZ, United States
Search 173 grants from Mark Nelson
Search grants from University of Arizona
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of a nonhuman primate model of fetal Zika virus infection and disease
Physiologic Mechanisms of Action of APP and APLP2 in Axon Targeting
(PQB2) Ontogeny of the tumor-immune interplay in a developmental malignancy
Strategies for the Prevention, Early Detection and Control of Chronic Dis.
Social Regulation of Reproductive Endocrinology
Recently added grants:
Role of HOS in Cell Transformation and Apoptosis
Statistical Methods for Evaluating Markers for Treatment Selection
Determinants of T Cell Fate in Transplantation Tolerance
Vitamin D and Photodynamic Therapy for Human Skin Cancer (SCC and BCC)
Secondary Prevention through Surveillance and Intervention
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32ES005533-01
Application #
3038333
Study Section
Immunology, Virology, and Pathology Study Section (IVP)
Project Start
1991-07-31
Project End
Budget Start
1991-02-01
Budget End
1992-01-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
University of Arizona
Department
Type
Schools of Medicine
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Related projects
NIH 1992
F32 ES
Cellular-Harvey-Ras Activation During Cisplatin-Initiate
Nelson, Mark A. / University of Arizona
NIH 1991
F32 ES
Cellular-Harvey-Ras Activation During Cisplatin-Initiate
Nelson, Mark A. / University of Arizona
Comments
Be the first to comment on Mark Nelson's grant